Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma

Clinical trial NCT02507076 · WITHDRAWN

Trial details

NCT number: NCT02507076
Sponsor: Albert Einstein College of Medicine
Status: WITHDRAWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Basal Cell Carcinoma of the Skin Eccrine Carcinoma of the Skin Recurrent Adult Soft Tissue Sarcoma Recurrent Melanoma Recurrent Skin Cancer Squamous Cell Carcinoma of the Skin Stage III Adult Soft Tissue Sarcoma Stage IIIB Melanoma Stage IIIC Melanoma Stage IV Adult Soft Tissue Sarcoma Stage IV Melanoma

Start date: 2012-04-01
Primary completion: 2014-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.